Viatris (VTRS) FCF Margin (2019 - 2026)
Viatris' (VTRS) quarterly FCF Margin came in at 9.93% in Q1 2026, down 522.0% year-on-year from 2.35% in Q1 2025, and down 40.05% quarter-over-quarter from 16.56% in Q4 2025.
Viatris (VTRS) FCF Margin (2019 - 2026) Analysis & Trends
Viatris' FCF Margin history runs 8 years deep, the most recent figure standing at 9.93% for Q1 2026.
- On a quarterly basis, FCF Margin fell 522.0% year-over-year to 9.93% in Q1 2026; TTM through Mar 2026 was 12.3%, a 105.0% decrease from a year earlier, with the FY2025 full-year figure at 13.55%, up 9.0% from the prior year.
- FCF Margin declined to 9.93% in Q1 2026 per VTRS's latest filing, from 16.56% in the prior quarter.
- Across five years, FCF Margin topped out at 25.7% in Q1 2022 and bottomed at 0.9% in Q4 2022.
- The 5-year median for FCF Margin is 15.42% (2024), against an average of 14.49%.
- Across the five-year window, FCF Margin soared 971 bps in 2023 and tumbled 934 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 0.9% in 2022, then surged by 1076 bps to 10.61% in 2023, then fell by 7 bps to 9.83% in 2024, then jumped by 68 bps to 16.56% in 2025, then slumped by 40 bps to 9.93% in 2026.
- Per Business Quant, the three latest VTRS FCF Margin figures stand at 9.93% (Q1 2026), 16.56% (Q4 2025), and 17.5% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.93% |
| Dec 31, 2025 | 16.56% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | 4.67% |
| Mar 31, 2025 | 15.15% |
| Dec 31, 2024 | 9.83% |
| Sep 30, 2024 | 19.98% |
| Jun 30, 2024 | 8.46% |
| Mar 31, 2024 | 15.42% |
| Dec 31, 2023 | 10.61% |
| Sep 30, 2023 | 18.79% |
| Jun 30, 2023 | 11.67% |
| Mar 31, 2023 | 24.76% |
| Dec 31, 2022 | 0.90% |
| Sep 30, 2022 | 18.81% |
| Jun 30, 2022 | 17.50% |
| Mar 31, 2022 | 25.70% |
| Dec 31, 2021 | 7.40% |
| Sep 30, 2021 | 21.34% |
| Jun 30, 2021 | 10.31% |